Pathway Genomics IPO

Pathway Genomics is a biotechnology company focused on providing users with the most validated and personalized healthcare information delivered to any device, the company’s program with IBM Watson is the first of its kind to merge artificial intelligence and deep learning with precision medicine, applicable to both consumers and providers.

Register for Details

For more details on financing and valuation for Pathway Genomics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Pathway Genomics

Forge green plus iconForge green minus icon

What is Pathway Genomics's funding to date?

Pathway Genomics has raised $127.23MM to date.
Forge green plus iconForge green minus icon

When was Pathway Genomics founded?

Pathway Genomics was founded in 2008.

Who are Pathway Genomics's major investors?

International Business Machines

Pathway Genomics Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
1/5/2016 Series E-1 $40MM raised $XXX.XX $XXX.XX
11/12/2014 Series D $35.78MM raised $XXX.XX $XXX.XX
4/1/2014 Series C $36.51MM raised $XXX.XX $XXX.XX
7/15/2009 Series B $11.75MM raised $XXX.XX $XXX.XX
7/1/2009 Series A $3.19MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: May 23, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.